🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Trevor Allred

Stock Analyst at Oppenheimer

(4.92)
# 224
Out of 5,162 analysts
44
Total ratings
87.1%
Success rate
83.3%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Trevor Allred

Palvella Therapeutics
Nov 20, 2026
Reiterated: Buy
Price Target: $232
Current: $146.58
Upside: +58.28%
BridgeBio Pharma
May 11, 2026
Rated: Hold
Price Target: n/a
Current: $78.01
Upside: -
Dianthus Therapeutics
May 11, 2026
Rated: Hold
Price Target: n/a
Current: $83.98
Upside: -
Innoviva
Feb 26, 2026
Downgraded: Buy
Price Target: $35
Current: $18.40
Upside: +90.22%
Ligand Pharmaceuticals
Nov 7, 2025
Reiterated: Buy
Price Target: $250 → $275
Current: $298.71
Upside: n/a
MBX Biosciences
Nov 7, 2025
Reiterated: Buy
Price Target: $38 → $80
Current: $53.42
Upside: n/a